DBC1 promotes anoikis resistance of gastric cancer cells by regulating NF-κB activity.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Oncology Report

• Publication date

  2015-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/or.2015.4007PMID 26035299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Screening of gastric cancer: who, when, and how.

  2014cited by this paper
• DBC1 is over-expressed and associated with poor prognosis in colorectal cancer

  2014cited by this paper
• Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB

  2013cited by this paper
• The IKK Inhibitor Bay 11-7082 Induces Cell Death Independent from Inhibition of Activation of NFκB Transcription Factors

  2013cited by this paper
• Expression of DBC1 and Androgen Receptor Predict Poor Prognosis in Diffuse Large B Cell Lymphoma.

  2013cited by this paper
• Anoikis molecular pathways and its role in cancer progression.

  2013cited by this paper
• Expression of SIRT1 and DBC1 Is Associated with Poor Prognosis of Soft Tissue Sarcomas

  2013cited by this paper
• Uncovering a key to the process of metastasis in human cancers: a review of critical regulators of anoikis

  2013cited by this paper
• The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis.

  2012cited by this paper
• Cellular FLICE-like inhibitory proteins (c-FLIPs): fine-tuners of life and death decisions.

  2012cited by this paper
• NF‐κB and the link between inflammation and cancer

  2012cited by this paper
• DBC1 phosphorylation by ATM/ATR inhibits SIRT1 deacetylase in response to DNA damage.

  2012cited by this paper
• Expression of SIRT1 and DBC1 in Gastric Adenocarcinoma

  2012cited by this paper
• Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis

  2012cited by this paper
• MiR-26a regulates cell cycle and anoikis of human esophageal adenocarcinoma cells through Rb1-E2F1 signaling pathway

  2012cited by this paper
• Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma.

  2011cited by this paper
• NF-κB in cancer: a matter of life and death.

  2011cited by this paper
• Overcoming anoikis – pathways to anchorage-independent growth in cancer

  2011cited by this paper
• Expression of DBC1 is associated with nuclear grade and HER2 expression in breast cancer.

  2011cited by this paper
• Identification of DBC1 as a transcriptional repressor for BRCA1

  2010cited by this paper
• Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

  2010cited by this paper
• NFκB: a promising target for natural products in cancer chemoprevention

  2010cited by this paper
• Deleted in breast cancer 1 (DBC1) is a dynamically regulated protein.

  2010cited by this paper
• DBC-1 mediates endocrine resistant breast cancer cell survival

  2010cited by this paper
• Repression of estrogen receptor beta function by putative tumor suppressor DBC1.

  2010cited by this paper
• Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma

  2009cited by this paper
• Identification and Characterization of a Novel Nuclear Protein Complex Involved in Nuclear Hormone Receptor-mediated Gene Regulation*

  2009cited by this paper
• Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment

  2009cited by this paper
• Deleted in Breast Cancer 1, a Novel Androgen Receptor (AR) Coactivator That Promotes AR DNA-binding Activity*

  2009cited by this paper
• Negative regulation of the deacetylase SIRT1 by DBC1

  2008cited by this paper
• DBC1 is a negative regulator of SIRT1

  2008cited by this paper
• Modulation of estrogen receptor α protein level and survival function by DBC-1

  2007cited by this paper
• Modulation of estrogen receptor alpha protein level and survival function by DBC-1.

  2007cited by this paper
• DBC2, a candidate for a tumor suppressor gene involved in breast cancer

  2002cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes.

  1999cited by this paper

• Metabolic reprogramming and signaling adaptations in anoikis resistance: mechanisms and therapeutic targets

  2025cites this paper
• Ring-Finger Protein 126 (RNF126) Promotes Anoikis Resistance and Peritoneal Colonization in Ovarian Cancer

  2025cites this paper
• The Duality of Collagens in Metastases of Solid Tumors

  2025cites this paper
• Prognostic and clinicopathological value of dbc1 expression in human cancers: a systematic review and meta-analysis

  2025cites this paper
• Anoikis resistance in gastric cancer: a comprehensive review

  2025cites this paper
• Anoikis Resistance in Cancer: Mechanisms, Therapeutic Strategies, Potential Targets, and Models for Enhanced Understanding.

  2025cites this paper
• Targeting anoikis resistance as a strategy for cancer therapy.

  2024cites this paper
• Versatile function of NF-ĸB in inflammation and cancer

  2024cites this paper
• Multifaceted roles of CCAR family proteins in the DNA damage response and cancer

  2024cites this paper
• Mechanistic insights into the dual role of CCAR2/DBC1 in cancer

  2023cites this paper
• A Novel Signature Based on Anoikis Associated with BCR-Free Survival for Prostate Cancer

  2023cites this paper
• Super-enhancer-associated gene CAPG promotes AML progression

  2023cites this paper
• MiR-342-5p protects neurons from cerebral ischemia induced-apoptosis through regulation of Akt/NF-κB pathways by targeting CCAR2.

  2022cites this paper
• CCAR2 promotes a malignant phenotype of osteosarcoma through Wnt/β-catenin-dependent transcriptional activation of SPARC.

  2021cites this paper
• PGPM_A_258761 345..352

  2020cites this paper
• IKBKB rs2272736 is Associated with Gastric Cancer Survival

  2020cites this paper
• CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis

  2020cites this paper
• Regulators and mechanisms of anoikis in triple-negative breast cancer (TNBC): A review.

  2019cites this paper
• Deleted in Breast Cancer 1 as a Novel Prognostic Biomarker for Digestive System Cancers: A Meta-Analysis

  2019cites this paper
• Deleted in breast cancer 1 as a potential prognostic biomarker in human cancers: a pooled analysis of 2,254 patients

  2019cites this paper
• Cell cycle and apoptosis regulator 2 at the interface between DNA damage response and cell physiology.

  2018cites this paper
• Shear stress promotes anoikis resistance of cancer cells via caveolin‐1‐dependent extrinsic and intrinsic apoptotic pathways

  2018cites this paper
• Helicobacter pylori‐induced miR‐135b‐5p promotes cisplatin resistance in gastric cancer

  2018cites this paper
• CCAR2 Is Required for Proliferation and Tumor Maintenance in Human Squamous Cell Carcinoma.

  2017cites this paper
• CCAR2 negatively regulates IL-8 production in cervical cancer cells

  2017cites this paper
• Overexpression of DBC1, correlated with poor prognosis, is a potential therapeutic target for hepatocellular carcinoma.

  2017cites this paper
• NF-κB Signaling in Gastric Cancer

  2017cites this paper